IP Library Granted Patent US 8,614,341
Granted Patent B2
US 8,614,341 · App. 13/320,176 · Granted Dec 24, 2013

Amorphous silibinin for the treatment of viral hepatitis

Inventors: Lucio Claudio Rovati (Monza, IT); Astrid Nagell (Hamburg, DE); Aguirre Jaime Xiol (Barcelona, ES); Prous Santiago Rull (Barcelona, ES); Ralf-Torsten Pohl (Speyer, DE); Ulrich Mengs (Rösrath, DE)
Assignee: Euromed S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,614,341
App. No.
13/320,176
Granted
Dec 24, 2013
Kind
B2
Abstract

The invention relates to a method for the preparation of amorphous silibinin (or its synonyms: silybin or silibin) derived from a milk thistle fruit extract having an increased release rate and improved absorbability or bioavailability, and to the use of amorphous silibinin for the treatment or prevention of liver diseases, preferably for the treatment of viral hepatitis, e.g. hepatitis B or C, in particular in a patient who will undergo or has undergone liver transplantation. Preferably, the amorphous silibinin is adapted for oral administration.

Claims (28)

1. A method for preparing amorphous silibinin comprising the following steps:

A.) extracting silibinin with ethyl acetate a solvent having a dipole moment of less than 2 Debye,

B.) separating the solvent phase from solid residues,

C.) concentrating the solvent phase at a temperature of less than 60° C.,

D.) combining the concentrate obtained in step C.) with ethanol and then combining it with hexane, concentrating the mixture, and distilling hexane off from said concentrated mixture,

E.) concentrating the intermediate product obtained in step D.),

F.) separating the solid phase,

G.) dissolving the solid phase obtained in step F.) with ethanol,

H.) adding activated charcoal,

I.) separating the charcoal from the liquid phase, concentrating the liquid and crystallizing silibinin therefrom,

J.) separating the crystals obtained in step I.) from the liquid phase, and if required, repeating steps G.), I.), J.) in order to enrich silibinin to a content of more than 95% by weight,

K.) optionally, filtrating, washing, drying and, if required, repeating these steps,

L.) combining the material obtained in step K.) with anhydrous alcohol, refluxing, cooling to 40° C., and either concentrating under vacuum or spray drying to obtain an amorphous-like fine powder,

M.) drying, milling, and homogenizing the obtained amorphous-like fine powder;

wherein the starting material is milk thistle or a part thereof.

2. The method according to claim 1 , wherein step A.) is performed at a temperature of 40-80° C.

3. The method according to claim 2 , wherein the temperature is 50-70° C.

4. The method according to claim 1 , wherein separating in step B.), F.), I.) and/or J.) is achieved by filtering.

5. The method according to claim 1 , wherein concentrating in step C.), D.) and/or L.) and/or drying in step K.) is performed under vacuum.

6. The method according to claim 1 , wherein concentrating in step C.) is performed at a temperature of less than 40° C.

7. The method according to claim 1 , wherein in step D.) and/or G.) the ethanol is added and the water content is adjusted to 130-180 g/L.

8. The method according to claim 1 , wherein concentrating in step E.) is performed at a temperature of less than 65° C.

9. The method according to claim 1 , wherein separating in step I.) is performed at a temperature of less than 80° C.

10. The method according to claim 9 , wherein the temperature is within the range of 50-60° C.

11. The method according to claim 1 , wherein in step L.) the anhydrous alcohol is an anhydrous C 1 -C 4 alcohol.

12. The method according to claim 11 , wherein the anhydrous C 1 -C 4 alcohol is ethanol.

13. The method according to claim 1 , wherein in step L.) the amorphous-like fine powder is obtained by concentrating under vacuum.

14. The method according to claim 1 , wherein in step L.) the amorphous-like fine powder is obtained by spray drying.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2016
From: EUROMED S.A.U.
To: MADAUS GMBH
Reel/Frame 037724/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2012
From: ROVATI, LUCIO CLAUDIO; NAGELL, ASTRID; XIOL, AGUIRRE JAIME; RULL, PROUS SANTIAGO; POHL, RALF-TORSTEN; MENGS, ULRICH
To: EUROMED S.A.
Reel/Frame 027520/0458 →
Priority Claims (3)
EP 09160322 · May 14, 2009 · regional
EP 09006663 · May 18, 2009 · regional
EP 09006804 · May 20, 2009 · regional
Continuity (1)
Related Publication 20120108825A1 · May 3, 2012